AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹20 Cr | ₹7.85 Cr | ₹11 Cr | ₹12 Cr | ₹4.73 Cr |
What is the latest Total Non-Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹20 Cr |
| Mar2025 | ₹7.85 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹4.73 Cr |
How is Total Non-Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 Cr | 158.51 | |
| Mar2025 | ₹7.85 Cr | -27.18 | |
| Mar2024 | ₹11 Cr | -9.70 | |
| Mar2023 | ₹12 Cr | 152.61 | |
| Mar2022 | ₹4.73 Cr | - | |
Compare Total Non-Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹237.2 Cr | -0.9% | -4.9% | -14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -0.9% |
-4.9% |
-14.7% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses